Global Oncology Companion Diagnostic Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: May-2021 | Id: MACRC-62898 | Geographical Scope: Global | Publisher: HNY Research
The global Oncology Companion Diagnostic market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Agilent Technologies, Inc. Myriad Genetics, Inc. Thermo Fisher Scientific Inc. Illumina, Inc. Abbott Qiagen N.V. Invivoscribe, Inc. ARUP Laboratories F. Hoffmann-La Roche Ltd. bioMérieux SA By Types: Polymerase Chain Reaction (PCR) Next-Generation Sequencing (NGS) Immunohistochemistry (IHC) In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) Others By Applications: Hospital Pathology/Diagnostic Laboratory Academic Medical Center Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Oncology Companion Diagnostic Revenue 1.5 Market Analysis by Type 1.5.1 Global Oncology Companion Diagnostic Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Polymerase Chain Reaction (PCR) 1.5.3 Next-Generation Sequencing (NGS) 1.5.4 Immunohistochemistry (IHC) 1.5.5 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) 1.5.6 Others 1.6 Market by Application 1.6.1 Global Oncology Companion Diagnostic Market Share by Application: 2022-2027 1.6.2 Hospital 1.6.3 Pathology/Diagnostic Laboratory 1.6.4 Academic Medical Center 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Oncology Companion Diagnostic Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Oncology Companion Diagnostic Market Players Profiles 3.1 Agilent Technologies, Inc. 3.1.1 Agilent Technologies, Inc. Company Profile 3.1.2 Agilent Technologies, Inc. Oncology Companion Diagnostic Product Specification 3.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Myriad Genetics, Inc. 3.2.1 Myriad Genetics, Inc. Company Profile 3.2.2 Myriad Genetics, Inc. Oncology Companion Diagnostic Product Specification 3.2.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Thermo Fisher Scientific Inc. 3.3.1 Thermo Fisher Scientific Inc. Company Profile 3.3.2 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Specification 3.3.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Illumina, Inc. 3.4.1 Illumina, Inc. Company Profile 3.4.2 Illumina, Inc. Oncology Companion Diagnostic Product Specification 3.4.3 Illumina, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Abbott 3.5.1 Abbott Company Profile 3.5.2 Abbott Oncology Companion Diagnostic Product Specification 3.5.3 Abbott Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Qiagen N.V. 3.6.1 Qiagen N.V. Company Profile 3.6.2 Qiagen N.V. Oncology Companion Diagnostic Product Specification 3.6.3 Qiagen N.V. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Invivoscribe, Inc. 3.7.1 Invivoscribe, Inc. Company Profile 3.7.2 Invivoscribe, Inc. Oncology Companion Diagnostic Product Specification 3.7.3 Invivoscribe, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 ARUP Laboratories 3.8.1 ARUP Laboratories Company Profile 3.8.2 ARUP Laboratories Oncology Companion Diagnostic Product Specification 3.8.3 ARUP Laboratories Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 F. Hoffmann-La Roche Ltd. 3.9.1 F. Hoffmann-La Roche Ltd. Company Profile 3.9.2 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Specification 3.9.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 bioMérieux SA 3.10.1 bioMérieux SA Company Profile 3.10.2 bioMérieux SA Oncology Companion Diagnostic Product Specification 3.10.3 bioMérieux SA Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Oncology Companion Diagnostic Market Competition by Market Players 4.1 Global Oncology Companion Diagnostic Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Oncology Companion Diagnostic Revenue Market Share by Market Players (2016-2021) 4.3 Global Oncology Companion Diagnostic Average Price by Market Players (2016-2021) 5 Global Oncology Companion Diagnostic Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Oncology Companion Diagnostic Market Size (2016-2021) 5.1.2 Oncology Companion Diagnostic Key Players in North America (2016-2021) 5.1.3 North America Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.1.4 North America Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Oncology Companion Diagnostic Market Size (2016-2021) 5.2.2 Oncology Companion Diagnostic Key Players in East Asia (2016-2021) 5.2.3 East Asia Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.2.4 East Asia Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Oncology Companion Diagnostic Market Size (2016-2021) 5.3.2 Oncology Companion Diagnostic Key Players in Europe (2016-2021) 5.3.3 Europe Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.3.4 Europe Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Oncology Companion Diagnostic Market Size (2016-2021) 5.4.2 Oncology Companion Diagnostic Key Players in South Asia (2016-2021) 5.4.3 South Asia Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.4.4 South Asia Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Oncology Companion Diagnostic Market Size (2016-2021) 5.5.2 Oncology Companion Diagnostic Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.5.4 Southeast Asia Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Oncology Companion Diagnostic Market Size (2016-2021) 5.6.2 Oncology Companion Diagnostic Key Players in Middle East (2016-2021) 5.6.3 Middle East Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.6.4 Middle East Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Oncology Companion Diagnostic Market Size (2016-2021) 5.7.2 Oncology Companion Diagnostic Key Players in Africa (2016-2021) 5.7.3 Africa Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.7.4 Africa Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Oncology Companion Diagnostic Market Size (2016-2021) 5.8.2 Oncology Companion Diagnostic Key Players in Oceania (2016-2021) 5.8.3 Oceania Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.8.4 Oceania Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Oncology Companion Diagnostic Market Size (2016-2021) 5.9.2 Oncology Companion Diagnostic Key Players in South America (2016-2021) 5.9.3 South America Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.9.4 South America Oncology Companion Diagnostic Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Oncology Companion Diagnostic Market Size (2016-2021) 5.10.2 Oncology Companion Diagnostic Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Oncology Companion Diagnostic Market Size by Type (2016-2021) 5.10.4 Rest of the World Oncology Companion Diagnostic Market Size by Application (2016-2021) 6 Global Oncology Companion Diagnostic Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Oncology Companion Diagnostic Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Oncology Companion Diagnostic Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Oncology Companion Diagnostic Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Oncology Companion Diagnostic Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Oncology Companion Diagnostic Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Oncology Companion Diagnostic Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Oncology Companion Diagnostic Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Oncology Companion Diagnostic Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Oncology Companion Diagnostic Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Oncology Companion Diagnostic Consumption by Countries 7 Global Oncology Companion Diagnostic Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Oncology Companion Diagnostic (2022-2027) 7.2 Global Forecasted Revenue of Oncology Companion Diagnostic (2022-2027) 7.3 Global Forecasted Price of Oncology Companion Diagnostic (2022-2027) 7.4 Global Forecasted Production of Oncology Companion Diagnostic by Region (2022-2027) 7.4.1 North America Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.3 Europe Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.7 Africa Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.9 South America Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Oncology Companion Diagnostic by Application (2022-2027) 8 Global Oncology Companion Diagnostic Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Oncology Companion Diagnostic by Country 8.2 East Asia Market Forecasted Consumption of Oncology Companion Diagnostic by Country 8.3 Europe Market Forecasted Consumption of Oncology Companion Diagnostic by Countriy 8.4 South Asia Forecasted Consumption of Oncology Companion Diagnostic by Country 8.5 Southeast Asia Forecasted Consumption of Oncology Companion Diagnostic by Country 8.6 Middle East Forecasted Consumption of Oncology Companion Diagnostic by Country 8.7 Africa Forecasted Consumption of Oncology Companion Diagnostic by Country 8.8 Oceania Forecasted Consumption of Oncology Companion Diagnostic by Country 8.9 South America Forecasted Consumption of Oncology Companion Diagnostic by Country 8.10 Rest of the world Forecasted Consumption of Oncology Companion Diagnostic by Country 9 Global Oncology Companion Diagnostic Sales by Type (2016-2027) 9.1 Global Oncology Companion Diagnostic Historic Market Size by Type (2016-2021) 9.2 Global Oncology Companion Diagnostic Forecasted Market Size by Type (2022-2027) 10 Global Oncology Companion Diagnostic Consumption by Application (2016-2027) 10.1 Global Oncology Companion Diagnostic Historic Market Size by Application (2016-2021) 10.2 Global Oncology Companion Diagnostic Forecasted Market Size by Application (2022-2027) 11 Global Oncology Companion Diagnostic Manufacturing Cost Analysis 11.1 Oncology Companion Diagnostic Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Oncology Companion Diagnostic 12 Global Oncology Companion Diagnostic Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Oncology Companion Diagnostic Distributors List 12.3 Oncology Companion Diagnostic Customers 12.4 Oncology Companion Diagnostic Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000